Page 120 - fbkCardioDiabetes_2017
P. 120

96        Stress Hyperglycemia or Diabetes - Which is bad in ICU?





              Highlights
              1.   Hyperglycaemia is a common barrier in critically
                 ill patients with or without diabetes.
              2.  Increased glucose levels  are  associated with
                 higher  in-hospital  mortality  and excess  health-
                 care costs.
              3.  Stress  hyperglycemia may be more  dangerous
                 than hyperglycemia in a diabetic patient.
              4.  Acute coronary syndromes and strokes are areas
                 were good glycemic control is essential and has
                 mortality benefits.
              Treatment  in an  intensive care setting remains con-
              troversial and a more relaxed conventional approach
              is used with an aim to avoid hypoglycemia.


              KEYWORDS
              Stress  hyperglycaemia,  Type  1 Diabetes, Type  2 di-
              abetes, Intensive care, Acute coronary syndrome,
              Stroke.


              References
              1.  Umpierrez GE, Isaacs SD, Bazargan  N, You X, Thaler LM, Kitabchi
                 AE. Hyperglycemia: an independent  marker of in-hospital  mortal-
                 ity in patients  with undiagnosed  diabetes.  J Clin Endocrinol  Metab.
                 2002;87(3):978-82.
              2.  Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, et
                 al. Glucose metabolism in patients with acute myocardial infarction and
                 no previous diagnosis of diabetes mellitus: a prospective study. Lancet.
                 2002;359(9324):2140-4.
              3.  Matz K, Keresztes K, Tatschl C, Nowotny M, Dachenhausen A, Brainin
                 M, et al. Disorders of glucose metabolism in acute stroke patients: an
                 underrecognized problem. Diabetes Care. 2006;29(4):792-7.
              4.  Krinsley JS. Association  between hyperglycemia  and  increased hospital
                 mortality in a heterogeneous population of critically ill patients. Mayo
                 Clin Proc. 2003;78(12):1471-8.
              5.  van den Berghe G, Wouters P, Weekers  F, Verwaest C,  Bruyninckx F,
                 Schetz M, et al. Intensive  insulin  therapy in critically  ill patients.  N
                 Engl J Med. 2001;345(19):1359-67.
              6.  Investigators  N-SS,  Finfer  S, Chittock  DR, Su  SY, Blair D, Foster  D, et
                 al. Intensive versus conventional glucose control in critically ill patients.
                 N Engl J Med. 2009;360(13):1283-97.
              7.  Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Mal-
                 hotra A, et al. Intensive insulin therapy and mortality among critically
                 ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ.
                 2009;180(8):821-7.
              8.  Weston  C, Walker  L, Birkhead J, National Audit of Myocardial  Infarc-
                 tion Project NIfCOR. Early impact of insulin treatment on mortality for
                 hyperglycaemic  patients  without known diabetes  who present  with an
                 acute coronary syndrome. Heart. 2007;93(12):1542-6.
              9.  Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia  an inde-
                 pendent  predictor  of poor outcome after acute stroke? Results  of a
                 long-term follow up study. BMJ. 1997;314(7090):1303-6.
              10.  Capes SE, Hunt D, Malmberg K,  Pathak P, Gerstein  HC. Stress  hyper-
                 glycemia and prognosis of stroke in nondiabetic and diabetic patients:
                 a systematic overview. Stroke. 2001;32(10):2426-32.

                                                         GCDC 2017
   115   116   117   118   119   120   121   122   123   124   125